Inventiva publie ses informations financières du 1er trimestre 2023¹ et fait un point sur ses activités
May 16, 2023 16:00 ET
|
INVENTIVA
Au 31 mars 2023, trésorerie et équivalents de trésorerie à 56,3 millions d’euros, dépôt court terme à 0,7 million d’euros2 et dépôt long terme à 9,3 millions d'euros3, contre 86,7 millions d’euros,...
Infant Bacterial Therapeutics AB (publ), Delårsrapport 1 januari – 31 mars 2023
May 08, 2023 07:00 ET
|
Infant Bacterial Therapeutics AB
VD kommenterar Under de senaste månaderna har det skett betydelsefulla framsteg inom utvecklingen av mikrobiom-läkemedel. Ferrings/Rebiotics produkt REBYOTA™ godkändes av FDA i slutet av förra året...
Infant Bacterial Therapeutics AB (publ), Interim report January 1-March 31, 2023
May 08, 2023 07:00 ET
|
Infant Bacterial Therapeutics AB
Message from the CEO Significant advancements have been made in the development of microbiome-based pharmaceuticals in the past few months. Ferring/Rebiotics' product REBYOTA™ was approved by the...
CSX Corp. Announces Date for First Quarter Earnings Release and Earnings Call
March 23, 2023 10:00 ET
|
CSX Corporation
JACKSONVILLE, Fla., March 23, 2023 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release first quarter financial and operating results after the market close on Thursday, April 20, 2023. This...
Infant Bacterial Therapeutics publicerar årsredovisning för 2022
March 22, 2023 16:30 ET
|
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ) publicerar idag årsredovisningen för räkenskapsåret 2022. Årsredovisningen finns tillgänglig på IBTs hemsida, www.ibtherapeutics.com under avsnittet...
Infant Bacterial Therapeutics publishes Annual Report for 2022
March 22, 2023 16:30 ET
|
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ) publishes today the Annual Report for 2022. The report is available on IBT´s website, ibtherapeutics.com under the section Ïnvestors & Media – Financial...
Pieridae Releases Q4 and Full Year 2022 Results, 2022 Reserves & Revises 2023 Guidance
March 22, 2023 07:30 ET
|
Pieridae Energy Limited
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORDISSEMINATION IN UNITED STATES CALGARY, Alberta, March 22, 2023 (GLOBE NEWSWIRE) -- Pieridae Energy Limited (“Pieridae” or the “Company”)...
Correction: Inventiva publie ses résultats financiers préliminaires pour l’exercice 2022¹
February 14, 2023 17:00 ET
|
INVENTIVA
Daix (France), Long Island City (New York, Etats-Unis), le 14 février 2023 – Inventiva (Euronext Paris et Nasdaq : IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement...
Correction: Inventiva reports preliminary financial results for Full-Year 2022¹
February 14, 2023 17:00 ET
|
INVENTIVA
Daix (France), Long Island City (New York, United States), February 14, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...
Inventiva reports preliminary financial results for Full-Year 2022¹
February 14, 2023 16:00 ET
|
INVENTIVA
Daix (France), Long Island City (New York, United States), February 14, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...